Oric Pharmaceuticals Newsroom

Citi Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Cuts Target Price to $13

Moomoo NewsNov 28 06:31 ET

Citi Sticks to Its Buy Rating for Oric Pharmaceuticals (ORIC)

TipRanksNov 28 06:19 ET

Oppenheimer Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $15

Moomoo NewsNov 13 08:34 ET

Stifel Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $20

Moomoo NewsNov 13 08:31 ET

JonesTrading Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $17

Moomoo NewsNov 12 17:31 ET

Promising Advancements in Cancer Treatment: Buy Rating for ORIC Pharmaceuticals

TipRanksNov 12 17:17 ET

H.C. Wainwright Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $21

Moomoo NewsNov 4 06:31 ET

Wells Fargo Initiates Oric Pharmaceuticals(ORIC.US) With Buy Rating, Announces Target Price $20

Moomoo NewsOct 31 07:31 ET

Oric Pharmaceuticals Initiated at Buy by Jones Trading

Dow JonesOct 31 07:18 ET

ORIC Pharmaceuticals Analyst Ratings

BenzingaOct 31 07:14 ET

JonesTrading Initiates Oric Pharmaceuticals(ORIC.US) With Buy Rating, Announces Target Price $17

Moomoo NewsOct 30 16:31 ET

H.C. Wainwright Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $21

Moomoo NewsSep 18 11:31 ET

Buy Rating Affirmed for Oric Pharmaceuticals Amid Promising Collaborations and Strategic Clinical Advances

TipRanksSep 18 10:47 ET

Wedbush Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $20

Moomoo NewsSep 10 08:34 ET

Oric Pharmaceuticals (ORIC) Gets a Buy From Wedbush

TipRanksSep 10 08:08 ET

ORIC Pharmaceuticals Analyst Ratings

BenzingaSep 6 11:29 ET

Stifel Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $20

Moomoo NewsSep 6 07:31 ET

Stifel Initiates Oric Pharmaceuticals(ORIC.US) With Buy Rating, Announces Target Price $20

Moomoo NewsSep 5 16:32 ET

H.C. Wainwright Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $21

Moomoo NewsAug 14 07:31 ET

Oppenheimer Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Cuts Target Price to $15

Moomoo NewsAug 13 08:33 ET